Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.
1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253545556
Next »

Week of Feb. 1, 2010: Company and People Notes: Cephalon Buys Mepha; BASi's CEO Retires; and More.

February 4, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Cephalon Buys Mepha; BASi's CEO Retires; and More.

Science and Sensibility

February 2, 2010
By:Michelle Hoffman
Pharmaceutical Technology

The death of a pioneer in molecular genetics recalls age-old questions about social fitness to ensure the ethical uses of scientific advances.

The Talk of the Lab

February 2, 2010
By:Control, a senior compliance officer
Pharmaceutical Technology

Sharing too much—or too little—information can have disastrous onsequences.

Is the Internet to Blame for Unsafe Drug Use?

February 2, 2010
By:Angie Drakulich
Pharmaceutical Technology

FDA impersonators and counterfeit drugs threaten the public's trust in online pharmacies.

Innovation Today, Rewards Tomorrow

February 2, 2010
By:Billy Tauzin
Pharmaceutical Technology

When it comes to healthcare rform, we must not overlook investment in innovative technologies.

Managing Change Control in a Changing Environment

February 2, 2010
By:Susan J. Schniepp
Pharmaceutical Technology

We never thought implementing complex changes could become more cumbersome.

A Bio View of Outsourcing

February 2, 2010
By:Eric Langer
Pharmaceutical Technology

Strategic rather than tactical considerations are driving biopharmaceutical outsourcing.

PAT: A New Dawn for Drug Product Quality

February 2, 2010
By:Angie Drakulich, Patricia Van Arnum
Pharmaceutical Technology

Leading experts share insight on the current and future direction of process analytical technology. This article contains bonus online material.

In the Field: Report from Europe

February 2, 2010
By:Sean Milmo
Pharmaceutical Technology

Regulators and industry move to require inspections of API manufacturing facilities.

1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253545556
Next »

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What factor do you think will be most significant in 2010 for determining the health of the market for contract manufacturing of active pharmaceutical ingredients?
The global economic recovery
The US economic recovery
Improved credit and financing flow to the small to emerging pharma/bio sector
Less restrictive inventory control by pharmaceutical companies
The level of competition from contract manufacturers in emerging markets
The global economic recovery
39%
The US economic recovery
14%
Improved credit and financing flow to the small to emerging pharma/bio sector
13%
Less restrictive inventory control by pharmaceutical companies
9%
The level of competition from contract manufacturers in emerging markets
25%
View Results
Eric LangerOutsourcing OutlookEric Langer A Bio View of Outsourcing
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advances in Custom Synthesis
Faiz kermaniSpotlightFaiz Kermani Another twist in the EU parallel trade saga?
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
FindPharma Custom Search
Featured Jobs

More Jobs

Click here